Clinical Associate Professor Rick Stell

Sophisticated AI analysis reveals efficacy of neuroprotective drug for severe stroke

New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective...